4//SEC Filing
NAGASAKI YASUSHI 4
Accession 0001387131-13-001996
CIK 0001420031other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 8:10 PM ET
Size
8.2 KB
Accession
0001387131-13-001996
Insider Transaction Report
Form 4
NAGASAKI YASUSHI
Chief Financial Officer
Transactions
- Other
Cnovertible Promissory Note
2012-06-29$388800.00/sh+388,800$151,165,440,000→ 117,818 totalExercise: $3.30From: 2012-06-29→ Common Stock (117,818 underlying) - Award
Incentive Stock Options
2013-02-28Exercise: $3.60Exp: 2023-02-27→ Common Stock
Footnotes (2)
- [F1]The principal amount of the Convertible Promissory Note plus unpaid accrued interest (10% per annum) is convertible into shares of the Issuer's common stock. The 117,818 shares represents the number of shares into which the principal amount of the Convertible Promissory Note may be converted (the "Convertible Shares'). The note is due on demand.
- [F2]The option vests on a cliff basis for the first one-third (1/3) granted and monthly on a prorata basis for the remaining two-thirds (2/3) thereafter in equal amounts (or as close to an equal amount as possible) over the next 24 months beginning on February 28, 2014.
Documents
Issuer
EMMAUS LIFE SCIENCES, INC.
CIK 0001420031
Entity typeother
Related Parties
1- filerCIK 0001517916
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 8:10 PM ET
- Size
- 8.2 KB